Axxelent receives its first US FDA Establishment Inspection Report (EIR)
The US FDA inspected the facility from June 17 to 21, 2024
Sign in
Sign in
Recover your password.
A password will be e-mailed to you.
Browsing Tag
Establishment Inspection Report (EIR)
Aurobindo Pharma gets EIR with VAI status from USFDA for Hyderabad facility
USFDA issues an EIR to the company when an inspection is satisfactorily closed
Strides arm receives EIR for its US facility
Strides Pharma Inc received EIR from the United States Food and Drug Administration (USFDA) for the inspection conducted at its…
Cipla announces closure of USFDA inspection at Patalganga facility
Following the inspection by USFDA in November last year, the company has received the Establishment Inspection Report (EIR),…